Accounts Payable, Current of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Universe Pharmaceuticals INC quarterly Accounts Payable, Current in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
Universe Pharmaceuticals INC Accounts Payable, Current for the quarter ending 30 Sep 2025 was $1,669,785,000, a 33875% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Universe Pharmaceuticals INC Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,669,785,000	+$1,664,870,238	+33875%	30 Sep 2025	20-F	29 Jan 2026	2025	FY
Q3 2024	$4,914,762	+$329,479	+7.2%	30 Sep 2024	20-F	29 Jan 2026	2025	FY
Q1 2024	$7,763,981	-$3,475,044	-31%	31 Mar 2024	6-K	20 Sep 2024	2024	Q2
Q3 2023	$4,585,283	+$1,509,890	+49%	30 Sep 2023	20-F	29 Apr 2025	2024	FY
Q1 2023	$11,239,025	+$7,593,582	+208%	31 Mar 2023	6-K	31 Aug 2023	2023	Q2
Q3 2022	$3,075,393	-$2,235,133	-42%	30 Sep 2022	20-F	30 Jan 2024	2023	FY
Q1 2022	$3,645,443			31 Mar 2022	6-K	16 Aug 2022
Q3 2021	$5,310,526	+$2,619,333	+97%	30 Sep 2021	20-F	10 Feb 2023	2022	FY
Q3 2020	$2,691,193			30 Sep 2020	20-F	31 Jan 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.